About My Health Careers Internship MedBlogs Contact us

Drug Manufacturers Form Consortium to Develop Genetic Tests on Side Effects

by Gopalan on September 28, 2007 at 12:57 PM
Font : A-A+

Drug Manufacturers Form Consortium to Develop Genetic Tests on Side Effects

Seven pharmaceutical giants have come together to form a group called the International Serious Adverse Events Consortium, the objective being to develop genetic tests to determine which patients would be at risk from dangerous drug side effects.

If drugs could be withheld from patients who have a genetic risk for serious side effects, it could not only protect the patients but might help manufacturers get their drugs approved or avoid having to remove them from the market.


"We have to remove drugs that are clearly offering patients benefits because a handful are getting these severe adverse reactions," said Duncan McHale, a researcher for Pfizer and co-chairman of the consortium's scientific management committee.

The consortium will start by trying to find genetic predictors of two side effects — serious liver toxicity and Stevens-Johnson syndrome, a rare but potentially fatal blistering of the skin. Both effects are associated with numerous drugs.

McHale said the side effects were rare enough that no single company had enough cases and enough patient DNA samples to find genetic risk factors. "The way to do the best science is for all to work together to get as many cases as possible," he said.

Arthur Holden, the chief executive of the consortium, said the companies would contribute guidance and money and the results will be put into the public domain, with none of the corporate sponsors having early access or being able to patent the findings, he said. Once the results are made public, any company or laboratory would be able to develop and sell genetic tests to predict side effects.

The new Serious Adverse Events group would rely largely on DNA samples that European academic researchers had already collected from people who suffered the severe liver toxicity or Stevens-Johnson syndrome after taking drugs.

Using DNA analysis chips, researchers will examine those patients' DNA at one million different spots, comparing it with the DNA of control subjects, to look for variations between the groups. The DNA of about 2,000 people will be analyzed, with results available in a year or two, Holden said.

The raw results would require further studies to show if the markers really do predict who might suffer the side effects. It is possible that no such markers will be validated.

Even if relevant genes are identified, it might not be economically possible to test all patients to screen out side effects that show up in as few as one in 100,000 people. Such economic factors are one reason that pharmacogenetics, the practice of tailoring drug therapy to patients using genetic tests, has been slow to catch on.

The consortium trend is seen as a possible way out. In addition to Pfizer, the companies involved in the new venture are Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Roche, Sanofi-Aventis and Wyeth.

The Food and Drugs Administration (FDA) has encouraged such groups, even helping to start some of them though a program called the Critical Path Initiative, which aims to speed drug development.

Source: Medindia

News A-Z
News Category
What's New on Medindia
Cervical Cancer Awareness Month 2022
Ultra-Low-Fat Diet
Goji Berries May Protect Against Age-Related Vision Loss
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Genetics and Stem Cells Signature Drug Toxicity Christianson Syndrome 

Recommended Reading
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex ......
Risks involved in Genetic Testing
It is imperative for a person who is considering genetic testing to weigh the pros and cons before ...
Genetic Testing Procedure
In most cases genetic testing is done using blood samples. Other tissues and body fluids like skin, ...
Genetic Testing of Diseases - FAQs
Genetic Testing of Diseases - FAQs...
Christianson Syndrome
Christianson syndrome is a condition that occurs due to mutations (abnormal changes) in the gene SLC...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)